Ivan Tornos is Chairman of the Board of Directors, President and Chief Executive Officer of Zimmer Biomet. He was appointed Chairman in May 2025 and President, CEO and a member of the Board of Directors in August 2023. Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. He was appointed as Chief Operating Officer in March 2021 with responsibility for overseeing all global businesses, leading global operations, clinical and medical education and R&D functions. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Prior to that, he was with C.R. Bard, most recently as President, Europe, Middle East and Africa Regions. He also served as Vice President at Covidien International, International Vice President with Baxter International, and spent over a decade in leadership assignments with Johnson & Johnson. Mr. Tornos is an alumnus of Harvard Business School's Advanced Management Program and completed programs at Southern Methodist University. He holds post-MBA credentials from Wharton, an MBA from the University of Miami and a BBA from the University of Georgia. Mr. Tornos serves on the Board of Directors of AdvaMed and as an independent director of PHC Holdings Corporation.